{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:19:52Z","timestamp":1790277592301,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T00:00:00Z","timestamp":1477353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007817","name":"University of Rzesz\u00f3w","doi-asserted-by":"crossref","award":["DS\/2014, DS\/2015"],"award-info":[{"award-number":["DS\/2014, DS\/2015"]}],"id":[{"id":"10.13039\/501100007817","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00213-016-4461-0","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T01:05:53Z","timestamp":1477357553000},"page":"281-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6\u00a0Hz-induced psychomotor seizures in mice"],"prefix":"10.1007","volume":"234","author":[{"given":"Piotr","family":"Tutka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria W.","family":"Kondrat-Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Zaluska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"\u017b\u00f3\u0142kowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Florek-\u0141uszczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarogniew J.","family":"\u0141uszczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,25]]},"reference":[{"key":"4461_CR1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00003495-199855030-00013","volume":"55","author":"JC Adkins","year":"1998","unstructured":"Adkins JC, Noble S (1998) Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy. Drugs 55:437\u2013460","journal-title":"Drugs"},{"key":"4461_CR2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-142-4-200502150-00005","volume":"142","author":"NR Anthonisen","year":"2005","unstructured":"Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE (2005) The effects of smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142:233\u2013239","journal-title":"Ann Intern Med"},{"key":"4461_CR3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/thoraxjnl-2013-203246","volume":"68","author":"P Aveyard","year":"2013","unstructured":"Aveyard P, West R (2013) Cytisine and the failure to market and regulate for human health. Thorax 68:989","journal-title":"Thorax"},{"key":"4461_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","volume":"47","author":"ME Barton","year":"2001","unstructured":"Barton ME, Klein BD, Wolf HH, White HS (2001) Pharmacological characterization of the 6\u00a0Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 47:217\u2013227","journal-title":"Epilepsy Res"},{"key":"4461_CR5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/clpt.2008.3","volume":"83","author":"NL Benowitz","year":"2008","unstructured":"Benowitz NL (2008) Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 83:531\u2013541","journal-title":"Clin Pharmacol Ther"},{"key":"4461_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","volume":"3","author":"JR Boissier","year":"1960","unstructured":"Boissier JR, Tardy J, Diverres JC (1960) Une nouvelle methode simple pour explorer l\u2019action \u00abtranquilisante\u00bb: le test de la cheminee. Med Exp (Basel) 3:81\u201384","journal-title":"Med Exp (Basel)"},{"key":"4461_CR7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-3565(25)05160-2","volume":"107","author":"WC Brown","year":"1953","unstructured":"Brown WC, Schiffman DO, Swinyard EA, Goodman LS (1953) Comparative assay of antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test. J Pharmacol Exp Ther 107:273\u2013283","journal-title":"J Pharmacol Exp Ther"},{"key":"4461_CR8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1014233102342","volume":"19","author":"M Cadart","year":"2002","unstructured":"Cadart M, Marchand S, Pariat C, Bouquet S, Couet W (2002) Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats. Pharm Res 19:209\u2013214","journal-title":"Pharm Res"},{"key":"4461_CR9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0028-3908(83)90251-4","volume":"22","author":"MP Caulfield","year":"1983","unstructured":"Caulfield MP, Higgins GA (1983) Mediation of nicotine-induced convulsions by central nicotinic receptors of the \u2018C6\u2019 type. Neuropharmacology 22:347\u2013351","journal-title":"Neuropharmacology"},{"key":"4461_CR10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s40262-015-0276-0","volume":"54","author":"W Cawello","year":"2015","unstructured":"Cawello W (2015) Clinical pharmacokinetic and pharmacodynamic profile of lacosamide. Clin Pharmacokinet 54:901\u2013914","journal-title":"Clin Pharmacokinet"},{"key":"4461_CR11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-3565(24)36376-1","volume":"280","author":"LE Chavez-Noriega","year":"1997","unstructured":"Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346\u2013356","journal-title":"J Pharmacol Exp Ther"},{"key":"4461_CR12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/B978-0-12-420118-7.00013-5","volume":"49","author":"PA Crooks","year":"2014","unstructured":"Crooks PA, Bardo MT, Dwoskin LP (2014) Nicotinic receptor antagonists as treatments for nicotine abuse. Adv Pharmacol 49:513\u2013551","journal-title":"Adv Pharmacol"},{"key":"4461_CR13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00023210-200923070-00002","volume":"23","author":"G Curia","year":"2009","unstructured":"Curia G, Biagini G, Perucca E, Avoli M (2009) Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders. CNS Drugs 23:555\u2013568","journal-title":"CNS Drugs"},{"key":"4461_CR14","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)35238-3","volume":"291","author":"MI Damaj","year":"1999","unstructured":"Damaj MI, Glassco W, Dukat M, Martin BR (1999) Pharmacological characterization of nicotine-induced seizures in mice. J Pharmacol Exp Ther 291:1284\u20131291","journal-title":"J Pharmacol Exp Ther"},{"key":"4461_CR15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/81566","volume":"26","author":"M De Fusco","year":"2000","unstructured":"De Fusco M, Becchetti A, Patrignani A, Annesi G, Gambardella A, Quattrone A et al (2000) The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 26:275\u2013276","journal-title":"Nat Genet"},{"key":"4461_CR16","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archinte.166.15.1553","volume":"166","author":"JF Etter","year":"2006","unstructured":"Etter JF (2006) Cytisine for smoking cessation, a literature review and a meta-analysis. Arch Intern Med 166:1553\u20131559","journal-title":"Arch Intern Med"},{"key":"4461_CR17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00702-014-1173-7","volume":"121","author":"M Florek-Luszczki","year":"2014","unstructured":"Florek-Luszczki M, Wlaz A, Kondrat-Wrobel MW, Tutka P, Luszczki JJ (2014a) Effects of WIN 55, 212-2 (a non-selective cannabinoid CB1 and CB 2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6\u00a0Hz psychomotor seizure model. J Neural Transm (Vienna) 121:707\u2013715","journal-title":"J Neural Transm (Vienna)"},{"key":"4461_CR18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejphar.2013.10.063","volume":"723","author":"M Florek-Luszczki","year":"2014","unstructured":"Florek-Luszczki M, Wlaz A, Luszczki JJ (2014b) Interactions of levetiracetam with carbamazepine, phenytoin, topiramate and vigabatrin in the mouse 6\u00a0Hz psychomotor seizure model\u2014a type II isobolographic analysis. Eur J Pharmacol 723:410\u2013418","journal-title":"Eur J Pharmacol"},{"key":"4461_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2015.01.003","volume":"130","author":"M Florek-Luszczki","year":"2015","unstructured":"Florek-Luszczki M, Wlaz A, Zagaja M, Andres-Mach M, Kondrat-Wrobel MW, Luszczki JJ (2015) Effects of WIN 55, 212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6\u00a0Hz-induced psychomotor seizures in mice. Pharmacol Biochem Behav 130:53\u201358","journal-title":"Pharmacol Biochem Behav"},{"key":"4461_CR20","doi-asserted-by":"crossref","first-page":"e0141221","DOI":"10.1371\/journal.pone.0141221","volume":"10","author":"C Giordano","year":"2015","unstructured":"Giordano C, Vinet J, Curia G, Biagini G (2015) Repeated 6-Hz corneal stimulation progressively increases FosB\/\u0394FosB levels in the lateral amygdala and induces seizure generalization to the hippocampus. PLoS One 10:e0141221","journal-title":"PLoS One"},{"key":"4461_CR21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/FTD.0b013e3181dcc5fb","volume":"32","author":"C Greenaway","year":"2010","unstructured":"Greenaway C, Ratnaraj N, Sander JW, Patsalos PN (2010) A high-performance liquid chromatography assay to monitor the new antiepileptic drug lacosamide in patients with epilepsy. Ther Drug Monit 32:448\u2013452","journal-title":"Ther Drug Monit"},{"key":"4461_CR22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","volume":"74","author":"C Gotti","year":"2004","unstructured":"Gotti C, Clementi F (2004) Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74:363\u2013396","journal-title":"Prog Neurobiol"},{"key":"4461_CR23","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/thoraxjnl-2012-203035","volume":"68","author":"P Hajek","year":"2013","unstructured":"Hajek P, McRobbie H, Myers K (2013) Efficacy of cytisine in helping smokers quit: systemic review and metaanalysis. Thorax 68:1037\u20131042","journal-title":"Thorax"},{"key":"4461_CR24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1124\/mol.107.044545","volume":"74","author":"JC Hoda","year":"2008","unstructured":"Hoda JC, Gu W, Friedli M, Phillips HA, Bertrand S, Antonarakis SE et al (2008) Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore. Mol Pharmacol 74:379\u2013391","journal-title":"Mol Pharmacol"},{"key":"4461_CR25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.0013-9580.2004.12704.x","volume":"45","author":"P Kwan","year":"2004","unstructured":"Kwan P, Brodie MJ (2004) Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 45:1141\u20131149","journal-title":"Epilepsia"},{"key":"4461_CR26","first-page":"1","volume":"18","author":"J Leaviss","year":"2014","unstructured":"Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW et al (2014) What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation Health Technol Assess 18:1\u2013120","journal-title":"A systematic review and economic evaluation Health Technol Assess"},{"key":"4461_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","volume":"96","author":"JT Litchfield","year":"1949","unstructured":"Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99\u2013113","journal-title":"J Pharmacol Exp Ther"},{"key":"4461_CR28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","volume":"58","author":"W L\u00f6scher","year":"1999","unstructured":"L\u00f6scher W (1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58:31\u201359","journal-title":"Prog Neurobiol"},{"key":"4461_CR29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0091-3057(03)00081-9","volume":"75","author":"J Luszczki","year":"2003","unstructured":"Luszczki J, Swiader M, Czuczwar M, Kis J, Czuczwar SJ (2003) Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. Pharmacol Biochem Behav 75:319\u2013327","journal-title":"Pharmacol Biochem Behav"},{"key":"4461_CR30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2013.10.020","volume":"720","author":"JJ Luszczki","year":"2013","unstructured":"Luszczki JJ, Wlaz A, Karwan S, Florek-Luszczki M, Czuczwar SJ (2013) Effects of WIN 55, 212-2mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice. Eur J Pharmacol 720:247\u2013254","journal-title":"Eur J Pharmacol"},{"key":"4461_CR31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2165\/11208340-000000000-00000","volume":"25","author":"KA Lyseng-Williamson","year":"2011","unstructured":"Lyseng-Williamson KA (2011) Spotlight on levetiracetam in epilepsy. CNS Drugs 25:901\u2013905","journal-title":"CNS Drugs"},{"key":"4461_CR32","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1126\/science.7569895","volume":"269","author":"DS McGehee","year":"1995","unstructured":"McGehee DS, Heath MJ, Gelber S, Devay P, Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692\u20131696","journal-title":"Science"},{"key":"4461_CR33","first-page":"233","volume":"1","author":"OA Meyer","year":"1979","unstructured":"Meyer OA, Tilson HA, Byrd WC, Riley MT (1979) A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1:233\u2013236","journal-title":"Neurobehav Toxicol"},{"issue":"Suppl 9","key":"4461_CR34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1167.2005.00326.x","volume":"46","author":"PN Patsalos","year":"2005","unstructured":"Patsalos PN (2005) Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies. Epilepsia 46(Suppl 9):140\u2013148","journal-title":"Epilepsia"},{"key":"4461_CR35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"E Perucca","year":"2002","unstructured":"Perucca E (2002) Pharmacological and therapeutic properties of valproate: a summary after 35\u00a0years of clinical experience. CNS Drugs 16:695\u2013714","journal-title":"CNS Drugs"},{"key":"4461_CR36","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1136\/bmj.f5198","volume":"347","author":"JJ Prochaska","year":"2013","unstructured":"Prochaska JJ, Das S, Benowitz NL (2013) Cytisine, the world\u2019s oldest smoking cessation aid. BMJ 347:5198","journal-title":"BMJ"},{"key":"4461_CR37","doi-asserted-by":"publisher","first-page":"e64541","DOI":"10.1371\/journal.pone.0064541","volume":"8","author":"M Puligheddu","year":"2013","unstructured":"Puligheddu M, Pillolla G, Melis M, Lecca S, Marrosu F, De Montis MG et al (2013) PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. PLoS One 8:e64541. doi: 10.1371\/journal.pone.0064541","journal-title":"PLoS One"},{"key":"4461_CR38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00007691-199604000-00008","volume":"18","author":"N Ratnaraj","year":"1996","unstructured":"Ratnaraj N, Doheny HC, Patsalos PN (1996) A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb lo59) in serum or plasma by high performance liquid chromatography. Ther. Drug Monit 18:154\u2013157","journal-title":"Ther. Drug Monit"},{"key":"4461_CR39","doi-asserted-by":"crossref","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2007) Dose translation from animal to human studies revisited. The FASEB Journal 22 (3):659\u2013661","DOI":"10.1096\/fj.07-9574LSF"},{"key":"4461_CR40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eplepsyres.2010.09.002","volume":"92","author":"NM Rowley","year":"2010","unstructured":"Rowley NM, White HS (2010) Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: correlation with other seizure and epilepsy models. Epilepsy Res 92:163\u2013169","journal-title":"Epilepsy Res"},{"key":"4461_CR41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/11599020-000000000-00000","volume":"26","author":"R Sankar","year":"2012","unstructured":"Sankar R (2012) GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. CNS Drugs 26:229\u2013244","journal-title":"CNS Drugs"},{"key":"4461_CR42","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s11064-014-1263-9","volume":"39","author":"A Schousboe","year":"2014","unstructured":"Schousboe A, Madsen KK, Barker-Haliski ML, White HS (2014) The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters. Neurochem Res 39:1980\u20131987","journal-title":"Neurochem Res"},{"key":"4461_CR43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1517\/17425255.2013.749239","volume":"9","author":"A Schulze-Bonhage","year":"2013","unstructured":"Schulze-Bonhage A (2013) Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy. Expert Opin Drug Metab Toxicol 9:105\u2013115","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4461_CR44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/ntr\/ntr138","volume":"13","author":"N Sood","year":"2011","unstructured":"Sood N, Hota D, Sahai AK, Chakrabarti A (2011) Nicotine reversal of anticonvulsant action of topiramate in kainic acid-induced seizure model in mice. Nicotine Tob Res 13:1084\u20131091","journal-title":"Nicotine Tob Res"},{"key":"4461_CR45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-4328(00)00200-X","volume":"113","author":"JA Stitzel","year":"2000","unstructured":"Stitzel JA, Lu Y, Jimenez M, Tritto T, Collins AC (2000) Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors. Behav Brain Res 113:57\u201364","journal-title":"Behav Brain Res"},{"key":"4461_CR46","first-page":"30","volume":"23","author":"S Stoyanov","year":"1972","unstructured":"Stoyanov S, Yanachkova M (1972) Tabex \u2013 therapeutic efficacy and tolerance (in Bulgarian). Savr Med 23:30\u201333","journal-title":"Savr Med"},{"key":"4461_CR47","first-page":"415082","volume":"2015","author":"HS Suresh","year":"2015","unstructured":"Suresh HS, Chakraborty A, Virupakshaiah A, Kumar N (2015) Efficacy and safety of levetiracetam and carbamazepine as monotherapy in partial seizures. Epilepsy Res Treat 2015:415082","journal-title":"Epilepsy Res Treat"},{"key":"4461_CR48","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s004240100614","volume":"442","author":"B Sutor","year":"2001","unstructured":"Sutor B, Zolles G (2001) Neuronal nicotinic acetylcholine receptors and autosomal dominant nocturnal frontal lobe epilepsy: a critical review. Pflugers Arch 442:642\u2013651","journal-title":"Pflugers Arch"},{"key":"4461_CR49","first-page":"777","volume":"58","author":"P Tutka","year":"2006","unstructured":"Tutka P, Zato\u0144ski W (2006) Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy. Pharmacol Rep 58:777\u2013798","journal-title":"Pharmacol Rep"},{"key":"4461_CR50","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1517\/13543784.17.10.1473","volume":"17","author":"P Tutka","year":"2008","unstructured":"Tutka P (2008) Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation. Expert Opin Investig Drugs 17:1473\u20131485","journal-title":"Expert Opin Investig Drugs"},{"key":"4461_CR51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1734-1140(13)70978-2","volume":"65","author":"P Tutka","year":"2013","unstructured":"Tutka P, Mr\u00f3z T, Bednarski J, Styk A, Ognik J, Mosiewicz J et al (2013) Cytisine inhibits the anticonvulsant activity of phenytoin and lamotrigine in mice. Pharmacol Rep 65:195\u2013200","journal-title":"Pharmacol Rep"},{"key":"4461_CR52","unstructured":"Tutka, P., Wahl, H., D\u0105browa, M., B\u0142a\u017cej, J., 2016. Cytisine as an effective treatment for nicotine addiction in Poland: 50\u00a0years of experience. In: 2016 Annual Meeting of the Society for Research on Nicotine and Tobacco. Chicago, 125."},{"key":"4461_CR53","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","volume":"321","author":"P Venault","year":"1986","unstructured":"Venault P, Chaputhier G, De Carvalho LP, Simiand J, Morre M, Dodd RH et al (1986) Benzodiazepines impair and betacarbolines enhance performance in learning and memory task. Nature 321:864\u2013866","journal-title":"Nature"},{"key":"4461_CR54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1375\/jsc.3.1.57","volume":"3","author":"D Vinnikov","year":"2008","unstructured":"Vinnikov D, Brimkulov N, Burjubaeva A (2008) A double-blind, randomised, placebo-controlled trial of cytisine for smoking cessation in medium-dependent workers. J Smok Cessat 3:57\u201362","journal-title":"J Smok Cessat"},{"key":"4461_CR55","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMoa1407764","volume":"371","author":"N Walker","year":"2014","unstructured":"Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V et al (2014) Cytisine versus nicotine for smoking cessation. N Engl J Med 371:2353\u20132362","journal-title":"N Engl J Med"},{"key":"4461_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/add.13464","author":"N Walker","year":"2016","unstructured":"Walker N, Bullen C, Barnes J, McRobbie H, Tutka P, Raw M et al (2016) Getting cytisine licensed for use worldwide: a call to action. Addiction. doi: 10.1111\/add.13464","journal-title":"Addiction"},{"key":"4461_CR57","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1102035","volume":"365","author":"R West","year":"2011","unstructured":"West R, Zato\u0144ski W, Cedzy\u0144ska M, Lewandowska D, Pazik J, Aveyard P et al (2011) Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med 365:1193\u20131200","journal-title":"N Engl J Med"},{"key":"4461_CR58","unstructured":"WHO Report on the Global Tobacco Epidemic, 2013, 12. http:\/\/apps.who.int\/iris\/bitstream\/10665\/85380\/1\/9789241505871_eng.pdf?ua=1 [last accessed 10 February 2016]."},{"key":"4461_CR59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eplepsyres.2009.06.003","volume":"86","author":"E Wojda","year":"2009","unstructured":"Wojda E, Wlaz A, Patsalos PN, Luszczki JJ (2009) Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6\u00a0Hz psychomotor seizure model. Epilepsy Res 86:163\u2013174","journal-title":"Epilepsy Res"},{"key":"4461_CR60","doi-asserted-by":"crossref","unstructured":"Xi ZX (2010) Preclinical pharmacology, efficacy and safety of varenicline in smoking cessation and clinical utility in high risk patients. Drug Health Patient Saf 2010:39\u201348","DOI":"10.2147\/DHPS.S6299"},{"key":"4461_CR61","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/tc.2006.016097","volume":"15","author":"W Zato\u0144ski","year":"2006","unstructured":"Zato\u0144ski W, Cedzy\u0144ska M, Tutka P, West R (2006) An uncontrolled trial of cytisine (Tabex) for smoking cessation. Tob Control 15:481\u2013484","journal-title":"Tob Control"},{"key":"4461_CR62","first-page":"30","volume-title":"Cancer incidence and mortality versus the demographic situation in Poland","author":"W Zato\u0144ski","year":"2014","unstructured":"Zato\u0144ski W, Sulkowska U, Przewo\u017aniak K, Zato\u0144ski M (2014) Malignant cancer epidemiology in Poland. In: Potrykowska A, Strzelecki Z, Szymborski J, Witkowski J (eds) Cancer incidence and mortality versus the demographic situation in Poland. Governmental Population Council, Warsaw, pp. 30\u201349 (In Polish)"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4461-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T20:40:34Z","timestamp":1749674434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4461-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,25]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["4461"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4461-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,25]]}}}